Status:

COMPLETED

PET-MRI in Diagnosing Patients With Colon or Rectal Cancer

Lead Sponsor:

Case Comprehensive Cancer Center

Conditions:

Recurrent Colon Cancer

Recurrent Rectal Cancer

Eligibility:

All Genders

22+ years

Phase:

NA

Brief Summary

This pilot clinical trial studies positron emission tomography (PET)-magnetic resonance imaging (MRI) and PET-computed tomography (CT) as diagnostic imaging in patients with colon and/or rectal cancer...

Detailed Description

PRIMARY OBJECTIVES: I. To test the diagnostic performance of PET- MRI in the staging of preoperative high-grade rectal cancer patients, defined by T3 stage or higher or N1 stage or higher or presence...

Eligibility Criteria

Inclusion

  • Either having a T3 (the cancer has grown through the muscularis propria and into the outermost layers of the colon or rectum but not through them) or higher, node positivity or metastatic lesion in the context of rectal cancer or being studied for colorectal cancer follow up, independent of the renal function
  • PET-CT should be requested by a referring physician; in the case of having an MR requested as well, it will be reported from the MRI images generated in the PET-MRI
  • Stable physical medical conditions to undergo a MRI
  • Informed consent must be given and signed prior to study enrollment

Exclusion

  • Refuse to give and/or sign the informed consent
  • Subjects who do not meet the above mentioned inclusion criteria
  • Subjects who have a pacemaker
  • Subjects who have a metallic prostheses either in the pelvis or in the abdomen that will interfere with the MR imaging of that anatomical area
  • Subjects who suffer from claustrophobia
  • Pregnant women
  • Cognitive impairment that affects the subject's ability to give consent

Key Trial Info

Start Date :

April 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 5 2014

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT01807117

Start Date

April 1 2013

End Date

March 5 2014

Last Update

May 18 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center

Cleveland, Ohio, United States, 44106-5065